| Financial Year |
March 31 2023 |
| Monetary Funds |
1,327,468,237.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
586,397,704.07 |
| Advances to Suppliers |
6,251,185.27 |
| Other Receivables |
6,987,987.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
134,501,896.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
246,735,388.83 |
| Total Current Assets |
2,629,065,750.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
801,057,912.64 |
| Investment Properties |
-- |
| Fixed Assetes |
15,827,029,261.89 |
| Under-construction Projects |
6,233,288,346.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,814,674,111.42 |
| R&D expenses |
-- |
| Goodwill |
156,195,333.44 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
85,913,791.83 |
| Other Non-Current Assets |
186,671,262.56 |
| Sub-Total of Non-Current Assets |
30,473,831,641.76 |
| Total Assets |
33,102,897,392.39 |
| Short-Term Loans |
1,211,430,305.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,500,000.00 |
| Accounts Payable |
505,933,319.85 |
| Accounts Received In Advance |
19,010,321.02 |
| Employee Compensation Payable |
201,931,716.20 |
| Taxes Payable |
66,785,947.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,027,360,990.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,747,975,531.16 |
| Other Current Liabilities |
524,941,098.51 |
| Sub-Total of Current Liabilities |
8,515,812,713.91 |
| Long-term Loans |
6,398,725,648.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
414,822,886.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,219,306.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,975,391,960.93 |
| Total Liabilities |
17,491,204,674.84 |
| Paid-In Capital(Or Share Stock) |
3,075,653,888.00 |
| Capital Surplus |
3,057,107,899.56 |
| Surplus Reserve |
791,239,968.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,843,445,606.95 |
| Minority Stockholder's Interest |
1,793,214,912.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,818,477,805.15 |
| Owner's Equity（Stockholder's Equity） |
15,611,692,717.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
33,102,897,392.39 |
